Clinical Trials Logo

Schizo Affective Disorder clinical trials

View clinical trials related to Schizo Affective Disorder.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04068857 Withdrawn - Schizophrenia Clinical Trials

Repetitive Transcranial Magnetic Stimulation (rTMS) Self-Referential Processing (rTMS-SRP)

rTMS-SRP
Start date: September 2019
Phase: N/A
Study type: Interventional

This will be a single site pilot study. 16 subjects with early phase psychosis (EPP), defined as medical record documentation of the onset of clinically significant psychotic symptoms within the past ten years, will be randomized 1:1 to double-blind treatment with 5 sessions of rTMS or sham stimulation directed at the bilateral precuneus over the course of 1 week. Subjects will undergo functional magnetic resonance imaging (fMRI) procedures, behavioral and cognitive assessments, and self-referential memory paradigm (SRMP) at baseline and immediately following the final rTMS or sham session. Contact with subjects will be conducted at two weeks after the end of study intervention for adverse event assessments. In the event new adverse events felt to be related to the study intervention have occurred following the termination of study procedures, subjects will be brought in for further safety assessments.

NCT ID: NCT04054973 Withdrawn - Schizophrenia Clinical Trials

L-arginine Study for Persistent Symptoms of Schizophrenia

Start date: September 11, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this research is to see if daily combination treatment of L-arginine and Kuvan changes brain chemistry in people experiencing schizophrenia as measured by MRS brain scans.